NRI arrested at Mangaluru Airport on arrival from UAE for torturing wife

Mysuru, Feb 14: Citing the coronavirus scare prevalent in the city, hotel owners have urged the civic corporation to shut down roadside food vends, calling them a risk to public health.

A team of the city Hotel Owners Association, led by president C Narayanagowda and honorary secretary Ravindra Bhat, met mayor Tasneem Bano and MCC commissioner Gurudatta Hegde on Tuesday and urged them to implement the high court’s ban on street food vending.

In a statement issued on Thursday, the association said it had raised the poor hygiene at such joints amid the coronavirus threat and increasing incidence of chikungunya and malaria in the city. There is no check on the ingredients or water used and the cleanliness of the kitchens and cooking staff, they pointed out. Many of the joints operate near drains and public urinals and don’t have running water for washing or cleaning utensils, they said. Besides, the vends dump unsegregated garbage and compromise pedestrian safety by blocking pavements, they alleged.

“As this involves the livelihood of the vendors, I will take a decision after discussions with the commissioner and elected representatives,” the mayor said while pointing out that MCC had issued identity cards to the vendors after collecting details about them and their stalls. She said the health and education standing committees would also be consulted.

Commissioner Hegde said MCC was planning to move the vendors to designated hawking zones to ensure their livelihood was not affected. He explained that any drive to remove the vends was fraught with law and order problems. “False cases have been filed against MCC officers whenever they conducted drives against footpath food vendors in non-hawking zones. We will consult with the city police commissioner before taking any steps,” he said.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Bengaluru, Apr 15: With the reporting of the death of an 80-yr-old female from Hirebagewadi taluk in Belagavi district, the number of persons, who were died due to COVID-19 related disease, increased to 12, in Karnataka on Wednesday.

According to official sources, the deceased was a relative of another COVID-19 infected person, was succumbed to death this morning at a designated Hospital in Belagavi district.